These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 34611960)

  • 1. Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: A simulation study.
    Pazzagli L; Andersen M; Sessa M
    Pharmacoepidemiol Drug Saf; 2022 Jan; 31(1):55-60. PubMed ID: 34611960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length.
    Gardarsdottir H; Souverein PC; Egberts TC; Heerdink ER
    J Clin Epidemiol; 2010 Apr; 63(4):422-7. PubMed ID: 19880282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepidemiological methods for computing the duration of pharmacological prescriptions using secondary data sources.
    Meaidi M; Støvring H; Rostgaard K; Torp-Pedersen C; Kragholm KH; Andersen M; Sessa M
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1805-1814. PubMed ID: 34247270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription duration and treatment episodes in oral glucocorticoid users: application of the parametric waiting time distribution.
    Laugesen K; Støvring H; Hallas J; Pottegård A; Jørgensen JOL; Sørensen HT; Petersen I
    Clin Epidemiol; 2017; 9():591-600. PubMed ID: 29180903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short look-back periods in pharmacoepidemiologic studies of new users of antibiotics and asthma medications introduce severe misclassification.
    Riis AH; Johansen MB; Jacobsen JB; Brookhart MA; Stürmer T; Støvring H
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):478-85. PubMed ID: 25601142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of uncertain exposure-A method to define switching and add-on in pharmacoepidemiology.
    Pazzagli L; Linder M; Reutfors J; Brandt L
    Pharmacoepidemiol Drug Saf; 2022 Jan; 31(1):28-36. PubMed ID: 34558772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting and variability of constructing medication treatment episodes in pharmacoepidemiology studies: A methodologic systematic review using the case study of DPP-4 inhibitors and cardiovascular outcomes.
    Weisman A; King LK; Mamdani M
    Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):939-950. PubMed ID: 32662222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using prescription registries to define continuous drug use: how to fill gaps between prescriptions.
    Nielsen LH; Løkkegaard E; Andreasen AH; Keiding N
    Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):384-8. PubMed ID: 18213736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substantial reduction in severe diarrheal morbidity by daily zinc supplementation in young north Indian children.
    Bhandari N; Bahl R; Taneja S; Strand T; Mølbak K; Ulvik RJ; Sommerfelt H; Bhan MK
    Pediatrics; 2002 Jun; 109(6):e86. PubMed ID: 12042580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for constructing treatment episodes and impact on exposure-outcome associations.
    Pazzagli L; Brandt L; Linder M; Myers D; Mavros P; Andersen M; Bahmanyar S
    Eur J Clin Pharmacol; 2020 Feb; 76(2):267-275. PubMed ID: 31758215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors.
    Jacobus S; Schneeweiss S; Chan KA
    Pharmacoepidemiol Drug Saf; 2004 Oct; 13(10):695-702. PubMed ID: 15386727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Adherence and Prescription Patterns Using Large-Scale Claims Data.
    Bjarnadóttir MV; Malik S; Onukwugha E; Gooden T; Plaisant C
    Pharmacoeconomics; 2016 Feb; 34(2):169-79. PubMed ID: 26660349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome misclassification: Impact, usual practice in pharmacoepidemiology database studies and an online aid to correct biased estimates of risk ratio or cumulative incidence.
    Hall GC; Lanes S; Bollaerts K; Zhou X; Ferreira G; Gini R
    Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1450-1455. PubMed ID: 32860317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refining estimates of prescription durations by using observed covariates in pharmacoepidemiological databases: an application of the reverse waiting time distribution.
    Støvring H; Pottegård A; Hallas J
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):900-908. PubMed ID: 28466973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constructing treatment episodes from concomitant medication logs: a prospective observational study.
    Kuramoto LK; Sobolev BG; Brasher PMA; Tang MW; Cragg JJ
    BMJ Open; 2020 Mar; 10(3):e034305. PubMed ID: 32161159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delay in filling the initial prescription for a statin: a potential early indicator of medication nonpersistence.
    Yu AP; Yu YF; Nichol MB; Gwadry-Sridhar F
    Clin Ther; 2008 Apr; 30(4):761-74; discussion 716. PubMed ID: 18498924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.
    Wong CM; Rabl A; Thach TQ; Chau YK; Chan KP; Cowling BJ; Lai HK; Lam TH; McGhee SM; Anderson HR; Hedley AJ
    Res Rep Health Eff Inst; 2012 Aug; (170):5-91. PubMed ID: 23316618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infertility-related stress and the risk of antidepressants prescription in women: a 10-year register study.
    Pedro J; Vassard D; Malling GMH; Hougaard CØ; Schmidt L; Martins MV
    Hum Reprod; 2019 Aug; 34(8):1505-1513. PubMed ID: 31339996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Descriptive analysis of the economic burden of treatment resistance in a major depressive episode.
    Cai Q; Sheehan JJ; Wu B; Alphs L; Connolly N; Benson C
    Curr Med Res Opin; 2020 Feb; 36(2):329-335. PubMed ID: 31540559
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimating Determinants of Multiple Treatment Episodes for Substance Abusers.
    Goodman AC; Hankin JR; Kalist DE; Peng Y; Spurr SJ
    J Ment Health Policy Econ; 2001 Jun; 4(2):65-77. PubMed ID: 11967467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.